---
{"dg-publish":true,"permalink":"/notes-in-endocrinology/nie-insta-review/tramadol-induced-adrenal-insufficiency/"}
---

**Overview:**

	Tramadol, a commonly prescribed opioid analgesic, has been associated with adrenal insufficiency, particularly when used chronically at high doses. This condition results from suppression of the hypothalamic-pituitary-adrenal (HPA) axis and direct oxidative damage to the adrenal glands, leading to decreased cortisol production.

  

**Mechanism of Adrenal Insufficiency:**


• **Suppression of the HPA Axis:**

	• Inhibits corticotropin-releasing hormone (CRH) release from the hypothalamus.
	
	• Reduces adrenocorticotropic hormone (ACTH) secretion from the pituitary gland.

• Decreases cortisol production by the adrenal glands.

• **Oxidative Stress:**

	• Promotes oxidative damage in the adrenal cortex.
	
	• Causes histopathological changes such as vacuolation of cells, pyknotic nuclei, and congested blood capillaries.

	• These effects are reversible upon discontinuation of tramadol.

  

**Clinical Evidence and Case Reports:**

  

• **Case Reports:**

	• A 21-year-old female on tramadol 100 mg four times daily developed adrenal insufficiency, which resolved after discontinuing the drug.

• **Experimental Studies:**

	• Rats administered tramadol at 80 mg/kg body weight for 3 months showed significant adrenal gland damage and decreased cortisol levels, which began to reverse after withdrawal.

• **Implications:**

	• Monitoring patients on long-term tramadol therapy for signs of adrenal insufficiency is crucial as the condition appears reversible upon discontinuation.

  

**Symptoms and Diagnosis:**

  

• **Symptoms:**

	• Fatigue, weakness, and dizziness
	
	• Abdominal pain, nausea, and vomiting
	
	• Hypotension

• **Diagnosis:**

	• Measuring serum cortisol and ACTH levels.

• Conducting an ACTH stimulation test to assess adrenal function.

	• Experimental studies indicate decreased levels of adrenocorticotropic hormones, aldosterone, cortisol, corticosterone, and dehydroepiandrosterone sulfate with chronic tramadol use.

  

**Management and Recommendations:**

  

• **Treatment:**

	• Discontinuing tramadol use is the primary treatment.
	
	• Glucocorticoid replacement therapy may be necessary to manage symptoms and restore normal adrenal function.
	
	• **Recommendations for Healthcare Providers:**
	
	• Monitor patients on long-term tramadol therapy for signs of adrenal insufficiency.
	
	• Educate patients about the risks associated with chronic tramadol use.
	
	• Consider alternative pain management strategies to minimize the risk of endocrine complications.
	
	  

**Conclusion:**

	Awareness and monitoring of tramadol-induced adrenal insufficiency are essential to mitigate these risks and ensure patient safety.